"Dignity Health - Cancer Institute at St. Joseph's Hospital and Medical Center - Phoenix, AZ is a cancer center that offers many services, including breast cancer, cardio-oncology, and gastrointestinal cancer. Visit Dignity Health - Cancer Institute at St. Joseph's Hospital and Medical Center - Phoenix, AZ located at 625 N 6th St, Phoenix, AZ. This Phoenix cancer center is one of the best in Arizona. As part of the Dignity Health network, Dignity Health - Cancer Institute at St. Joseph's Hospital and Medical Center - Phoenix, AZ is dedicated to delivering high quality, compassionate care and access to Phoenix and nearby communities. We are located on the Phoenix Biomedical Campus in downtown Phoenix."

During the past decade, Arizona Cancer Center conducted 161 clinical trials. In the 10-year time frame, 161 clinical trials started and 113 clinical trials were completed, i.e. on average, 70.2% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 51 clinical trials were completed. i.e. 81% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 85 trials, followed by "University of Arizona" with 59 trials sponsored, "Children's Oncology Group" with 40 trials sponsored, "Radiation Therapy Oncology Group" with 21 trials sponsored and "Bristol-Myers Squibb" with 21 trials sponsored. Other sponsors include 289 different institutions and companies that sponsored additional 175 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 217 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 12 trials as a collaborator and "Merck Sharp & Dohme LLC" with 9 trials as a collaborator. Other collaborators include 111 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Cancer Center" are "Breast Cancer" (47 trials), "Leukemia" (37 trials), "Melanoma" (27 trials), "Lymphoma" (25 trials) and "Lung Cancer" (23 trials). Many other conditions were trialed in "Arizona Cancer Center" in a lesser frequency.

Most popular intervention types in "Arizona Cancer Center" are "Drug" (427 trials), "Biological" (102 trials), "Radiation" (69 trials), "Procedure" (50 trials) and "Other" (47 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (45 trials), "cyclophosphamide" (38 trials), "etoposide" (31 trials), "filgrastim" (31 trials) and "cisplatin" (28 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Cancer Center" are 428 trials for "All" genders, 64 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are NaN active trials in "Arizona Cancer Center". 1 are not yet recruiting, 49 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 353 completed trials in Arizona Cancer Center, undefined suspended trials, and 60 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Cancer Center, 104 "Phase 1" clinical trials were conducted, 254 "Phase 2" clinical trials and 143 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 22 trials that are defined as “Not Applicable".